Transaortic septal myectomy: techniques and pitfalls

Area of Science:

• Cardiology
• Genetics
• Congenital Heart Disease

Background:

• Hypertrophic cardiomyopathy (HCM) is a common genetic heart condition affecting up to 1 in 200 individuals.
• Left ventricular outflow tract (LVOT) obstruction in HCM necessitates treatment to alleviate symptoms and prevent sudden cardiac death.

Purpose of the Study:

• To compare the efficacy and safety of surgical myectomy versus percutaneous ablation for treating obstructive HCM.
• To establish surgical myectomy as the gold standard for managing subaortic obstruction in HCM.

Main Methods:

• Review of existing literature on treatments for obstructive HCM.
• Analysis of complication rates and long-term effectiveness of surgical myectomy and percutaneous ablation.
• Evaluation of the degree and duration of LVOT obstruction reduction for both procedures.

Main Results:

• Both surgical myectomy and percutaneous ablation are effective in treating LVOT obstruction.
• Surgical myectomy demonstrates a significantly lower complication rate compared to percutaneous ablation.
• Myectomy provides a more complete and sustained reduction in LVOT obstruction.

Conclusions:

• Surgical myectomy is the preferred and gold standard treatment for obstructive hypertrophic cardiomyopathy.
• Patients with obstructive HCM benefit from myectomy due to its superior safety and long-term efficacy profile.